International Journal of Medical Research & Health Sciences (IJMRHS)
ISSN: 2319-5886 Indexed in: ESCI (Thomson Reuters)
Gamal Lotfy
Department of Critical Care Medicine, Beni Suef University, Beni Suef, EgyptPublications
-
Research Article
Usage of HbA1c as a Marker to Assess Progression of COVID-19
Author(s): Gamal Lotfy, Sherif Sabri*, Mohamed Abo Hamila and Ahmed Yassien
Objective: To assess the impact of diabetes on the course of COVID-19 disease in critically ill patients by measuring HbA1c in the first 48 hours of admission and follow-up severity of the disease. Background: Poor glycemic management has been linked to increased mortality from previous viral pandemics, including H1N1 flu and SARS. Incorporating diabetes status assessment into risk management for COVID-19 patients is currently proposed by many investigations. Methods: A retrospective cohort study was conducted on 40 critically ill patients during the period from October 2021 to April 2022 on patients admitted to the critical care department in Beni-Suef university hospital. HbA1c was measure at first 48 hours from admission. Results: This study was conducted on 40 patients. Overall, 50% o.. Read More»
Select your language of interest to view the total content in your interested language